Company
Olema Pharmaceuticals, Inc. (OLMA)
Standardized SEC financial data for Olema Pharmaceuticals, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001750284 · NASDAQ · Pharmaceutical Preparations.
Return on equity
-34.0%
Free cash flow
-$146.9M
Current ratio
9.95×
EPS (diluted)
$-1.87
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| R&D expense | $13.7M | $51.1M | $82.3M | $86.1M | $124.5M | $157.7M |
| SG&A expense |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $338.5M | $287.3M | $204.4M | $261.8M | $434.1M | $505.4M |
| Total current assets |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$19.9M | -$50.7M | -$82.1M | -$83.7M | -$104.4M | -$146.7M |
| Capital expenditures |
Get OLMA data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/OLMA/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/OLMA/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"